New drug is greeted

A new drug to treat attention deficit hyperactivity disorder
(ADHD) has been cautiously welcomed by mental health charity

According to its manufacturer, atomoxetine can provide 24-hour
relief from the symptoms of ADHD in children and adolescents.

Dinah Morley, acting director of YoungMinds, said that it is
always “useful” to have a new option available, as not every child
responds to Ritalin which is often prescribed for ADHD.

The drug’s brand name is Strattera. It is manufactured by
Eli Lilly.

More from Community Care

Comments are closed.